Professor Tom Moody from Ballymena exceeds 100 technical publications since tenure at Almac

Professor Tom Moody

PROFESSOR Tom Moody from Ballymena has reached an impressive milestone of over 100 peer reviewed publications since the beginning of his tenure with Almac Group, global contract development and manufacturing organisation headquartered in Craigavon.

Prof. Moody is VP of Technology Development and Commercialisation at Almac Sciences, part of the Almac Group, with more than 18 years of extensive academic and industry experience. He is also a tenured honorary professor at Queen’s University Belfast in the area of Green Chemistry.

Professor Moody is a seasoned technical expert in chiral chemistry and biocatalysis.

In recent years, his publications have centred on the economic and environmental benefits of “green” chemical methods, including biocatalysis, a direct and simple way to synthesise complex achiral and chiral compounds, and most recently innovations in continuous flow chemistry.

At Almac Sciences and Arran Chemical Company, Professor Moody is responsible for driving new technology processes from conception to commercial scale-up across multi-disciplinary research including enzyme engineering, biocatalysis, flow chemistry, isotope chemistry, custom synthesis and commercial production.

He previously held the role of Head of Biocatalysis and Isotope Chemistry, where he led the development of Almac Sciences’ Biocatalysis Technology platform selectAZymeTM.

He also played an integral role in the integration of Arran Chemical Company Ltd into Almac Sciences and ensured smooth transfer of manufacturing projects from Craigavon to the Arran site in Athlone, Ireland.

Professor Moody said: “At Almac Sciences, it is a fundamental value of our organisation to be innovative and share acquired technical knowledge that will advance our industry, particularly in areas that can reduce the environmental impact and cost of chemical production.

“I am grateful for the many opportunities I have received to share the innovative methods we’re developing with the wider industry and academic communities through publication and look forward to the continued opportunity to do so in the future.”

Leave a reply